Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    A Closer Look At China's New E-Cigarette Regulations

    With the implementation of the Management Rules of E-cigarettes and the forthcoming effective date for the GB Standard on E-cigarettes (October 1, 2022), China has been regularly updating its e-cigarette regulations.
    GlobalFood, Drugs, Healthcare, Life Sciences
    Keller & Heckman
    Keller & Heckman
  • Article

    China Monthly Antitrust Update - April 2023

    On March 24, 2023, the State Administration for Market Regulation ("SAMR") issued four supporting regulations of the Anti-monopoly Law, namely the Provisions on Curbing the Abuse of Administrative Power...
    ChinaAntitrust/Competition Law
    Dentons
    Dentons
Article

Chinese Regulators Continue Enforcement Actions Against Medical Insurance Fraud

In recent years, fraud against China's state-run medical insurance program has been one of the major focus areas for both criminal and administrative enforcement.
ChinaCriminal Law
Arnold & Porter
Arnold & Porter
  • Article

    Overview Of Recent Anti-Corruption Enforcement Actions In The Pharmaceutical Industry In China

    On May 8, 2023, the National Health Commission of the People's Republic of China (the "PRC"), along with 13 other government departments...
    ChinaCriminal Law
    Sheppard
    Sheppard
  • Article

    Brief Analysis Under Anti-Monopoly Law ("AML") Of The Management Model To Ensure Distributors A Minimum Resale Profit Margin In The Healthcare Industry

    In early 2016, the Price Supervision and Anti-monopoly Bureau of China's National Development and Reform Commission issued the article "Key Issues on Price Supervision and Anti-monopoly in 2016" . . .
    ChinaFood, Drugs, Healthcare, Life Sciences
    JunHe Law Office
    JunHe Law Office
  • Article

    Education Sector – Implications Arising From COVID-19

    Since its outbreak in December 2019, and at the time of writing, the novel Coronavirus (COVID-19) has infected more than 79,000 people and killed...
    ChinaConsumer Protection
    Clyde & Co
    Clyde & Co
  • Article

    China's State Council Modernizes Cosmetic Regulation

    China's State Council released the new Cosmetic Regulation (the "New Regulation") on June 16, 2020, which is a major overhaul of the current 30-year-old Cosmetic Regulation
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    中国在医疗和生物技术领域的外资新政策:推动创新发展与加强专利保护

    2024年9月初,中国宣布了两项重大政策调整,旨在进一步向外资开放医疗保健和生物技术行业。这些政策包括在四个自由贸易区(FTZ)...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Lusheng Law Firm
    Lusheng Law Firm
  • Article

    医疗机构投资并购之法律尽职调查实务分析

    结合现行金融监管规定及目前司法案例来看,第93条对营业信托中通道业务及事务类信托的界定以及其效力认定的指引并非新创,是对现行监管&#
    ChinaWealth Management
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    The Remaining 2024 Congressional Agenda

    When the U.S. House of Representatives and Senate return Sept. 9 for the final "sprint" of the legislative session, Congress will have only three weeks in September, break for elections...
    GlobalGovernment, Public Sector
    Greenberg Traurig
    Greenberg Traurig
  • Article

    Navigating China's Health Transformation: Opportunities And Challenges For Multinationals

    With the core goal of achieving health equity by 2030 — meaning the elimination of health disparities to give all Chinese citizens a fair opportunity to be healthy — Healthy China 2030 stands...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ankura Consulting Group LLC
    Ankura Consulting Group LLC
  • Article

    Patenting Medical Use Inventions In China

    A medical use of a product may relate to i) the use of a new drug to treat a disease ("first medical use"); ii) the use of a known drug to treat a new disease...
    ChinaFood, Drugs, Healthcare, Life Sciences
    CCPIT Patent and Trademark Law Office
    CCPIT Patent and Trademark Law Office
  • Article

    Applicability Of Force Majeure In The Light Of Coronavirus Outbreak

    A large number of electronics and chemical companies, pharmaceutical firms and those from the manufacturing sector are witnessing obstacles in the supply chain due to the outbreak of coronavirus.
    ChinaCorporate/Commercial Law
    IPO Pang Xingpu
    IPO Pang Xingpu
  • Article

    The China Experience – Understanding The Evolution Of The COVID-19 Crisis

    The COVID-19 virus was first identified in China in December 2019, although the scale of the problem only became apparent during the Chinese New Year Holiday at the end of January.
    ChinaStrategy
    Mayer Brown
    Mayer Brown
  • Article

    Pharma Remains An Enforcement Focus In China – SAMR Orders Unwinding Of A Completed Pharma Deal

    Recent years have seen regulator focus on the pharmaceutical sector in China intensify and enforcement has become a key priority. A recent decision by the China's State Administration...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    Donations And Grants In China: Compliance Controls Beyond T&E

    Additionally, it may be worthwhile to understand the level of compliance controls employed by the intermediary to assess third-party compliance risks.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    速评《美国优先投资政策备忘录》对中国生物医药行业的潜在影响

    当地时间2025年2月21日,美国总统特朗普发布了一份名为《美国优先投资政策》(America First Investment Policy)的备忘录("备忘录")
    ChinaGovernment, Public Sector
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    Q4 2019 Quarterly VC Update: Nisa Leung On The State Of Venture Capital Investing

    By the time we went to publish this interview, it was a significant factor in the state of venture capital investing and, more broadly, our global economy.
    ChinaCorporate/Commercial Law
    Cooley LLP
    Cooley LLP
  • Article

    China Issues New Telemedicine Opinions For China And Foreign-Based Providers

    Telemedicine providers and vendors doing business in China, whether based in China, the United States, or elsewhere, received new guidance on the use of telemedicine.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    China Released Draft Medical Device Law For Comments

    On August 28, 2024, the National Medical Products Administration (NMPA) released the Medical Device Administration Law (Draft for Comment)...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Han Kun Law Offices
    Han Kun Law Offices
  • Showing 121–140 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics